The risk of mpox importation and subsequent outbreak potential in Chinese mainland: a retrospective statistical modelling study.

"availability of data and materials all code and publicly accessible data used during the study are available at https://github com/dxw-sola1015/mpox-importation-risk . availability of data and materials all code and publicly accessible data used during the study are available at https://github com/dxw-sola1015"

"availability of data and materials all code and publicly accessible data used during the study are available at https://github com/dxw-sola1015/mpox-importation-risk ."

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsHongjie Yu received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, Shanghai Roche Pharmaceutical Company, and SINOVAC Biotech Ltd. None of these are related to this study. Hongjie Yu is an editorial board member of the journal Infectious Diseases of Poverty. He was not involved in the peer-review or handling of the manuscript. Competing interests Hongjie Yu received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, Shanghai Roche Pharmaceutical Company, and SINOVAC Biotech Ltd. None of these are related to this study. Hongjie Yu is an editorial board member of the journal Infectious Diseases of Poverty. He was not involved in the peer-review or handling of the manuscript."

"Funding This study was supported by grants from Key Program of the National Natural Science Foundation of China (82130093)."